Biotron Limited

ASX:BIT ISIN:AU000000BIT4

Biotron Limited (Biotron) (ASX:BIT) (OTCMKTS:BITRF) is leading the way in the development of revolutionary new treatments for serious viral diseases such as HIV and Hepatitis C virus (HCV). Biotron has an impressive pipeline of clinical programs developing first-in-class antiviral drugs. 
 
    

View in Other Languages

News

Biotron Limited (ASX:BIT) Recently Announced Key Milestone in Clinical Trial for Hepatitis and HIV

🕔8/16/2013 12:13:30 PM 6713

Biotron Limited (ASX:BIT) (OTCMKTS:BITRF) was pleased to recently announce that it has achieved another key milestone, with the final patient enrolled in an important Phase 2 clinical trial of BIT225 in patients co-infected with Hepatitis C virus (HCV) and HIV.

Read Full Article

Asian Activities Report for September 30, 2011: Neon Energy (ASX:NEN) Sixth Well Successfully Brought Onstream in North San Ardo Oil Field, California

🕔9/30/2011 12:00:34 PM 12149

Asian Activities Report for September 30, 2011 includes: Neon Energy Limited (ASX:NEN) says today that the recently drilled Lombardi 19-27H development well in the North San Ardo oil field, onshore California, has been brought onstream; India Resources Limited (ASX:IRL) has signed a A$249M coal operations contract with Prism Cement Limited (BOM:500338) to develop and operate the first phase of Prism's Sial Ghoghri coal mine; Guildford Coal Limited (ASX:GUF) has upgraded its Exploration Targets at its Mongolian coal projects to 30Mt to 1.380Bt; Tissue Therapies Limited (ASX:TIS) will start the sales of VitroGro(R) for the treatment of chronic wounds in the UK and Europe during the second quarter of 2012; Biotron Limited (ASX:BIT) has commenced a human trial of its lead HIV drug candidate, BIT225; Circadian Technologies Limited (ASX:CIR) has submitted an investigational new drug application to the FDA to initiate clinical studies of VGX-100.

Read Full Article
###

35,896 COMPANY PROFILE VIEWS

  • This Page Viewed: (Last 7 Days: 20) (Last 30 Days: 71) (Since Published: 8702) 

Company Data

    Principal Sector
  • Health & Pharm 
  • Principal Industry
  • Biotechnology 
  • Listed
  • 2001/01/24 
  • Homepage
  • www.biotron.com.au

More News Results

  • 2024/07/11: Letter to Shareholders*
  • 2024/06/26: Webinar Investors Presentation*
  • 2024/06/25: BIOTRON CLINICAL TRIAL RESULTS WEBINAR*
  • 2024/06/19: BIT225 Phase 2 HIV Efficacy Trial Meets Primary Objectives*
  • 2024/05/23: Change of Share Registry address*
  • 2024/04/26: Quarterly Activities/Appendix 4C Cash Flow Report*
  • 2024/04/05: POSITIVE OUTCOMES IN BIT225 PHASE 2 CLINICAL TRIAL IN HIV*
  • 2024/03/27: Response to ASX Price Query*
  • 2024/02/27: Half Yearly Report and Accounts*
*refer to company website